Counterfeit Prescription Drug Profits
“Who’s Benefiting from Unsafe Drugs?” was the second panel of the Counterfeit Drug Forum held by the Partnership for Safe Medicines at the National Press Club.
Panelists talked about who benefits from unsafe drugs. Topics included enforcement and prosecution efforts and difficulties, and the trafficking of… read more
Panelists talked about who benefits from unsafe drugs. Topics included enforcement and prosecution efforts and difficulties, and the trafficking of controlled prescription drugs such as Oxycontin. The panelists responded to questions from members of the audience. Dr. Bryan Liang moderated.
People in this video
Charlie Chicon Executive Director National Association of Drug Diversion Investigators
Jeffrey Gren Director Department of Commerce->Office of Health and Consumer Goods
Robert L. Hill Chief Drug Enforcement Administration->Pharmaceutical Investigations Section
Nancy Kennedy Senior Operations Manager U.S. Food and Drug Administration->Office of Criminal Investigations
Bryan A. Liang M.D. Vice President Partnership for Safe Medicines
- Partnership for Safe MedicinesPartnership for Safe Medicines
More Videos From
Partnership for Safe Medicines: Counterfeit Drug ForumMore Videos
Problem of Counterfeit Prescription Drugs
The Partnership for Safe Medicines held a forum on counterfeit prescription drugs. Scott LaGanga opened the discussion with an overview…
Counterfeit Prescription Drugs
Scott Williams and Tim Mackey presented their research on counterfeit drugs.
Drug Safety and Security
Panelists discussed drug safety and security, including the impact of counterfeit drugs on the industry. They also…
International Anti-Counterfeit Prescription Drug Efforts
Panelists talked about international efforts to investigate counterfeit prescription drug operations. Topics included…